Valo Health

Valo Health is a technology company that is transforming the drug discovery and development process leveraging human-centric data and AI.

Valo Health uses artificial intelligence, human health data, and predictive chemistry to discover and develop new medicines. Its technology analyzes large-scale patient data to identify disease targets and understand biological causes, then combines those insights with computational modeling and laboratory testing to design and evaluate drug candidates. Valo’s work covers areas including cardiovascular, metabolic, renal, neurological, and cancer diseases.

Lantern Pharma

Lantern Pharma is a clinical stage pharmaceutical company that is revolutionizing the field of oncology. They are pioneering the use of Artificial Intelligence, Machine Learning, and genomics to develop targeted cancer therapies.

Lantern Pharma uses artificial intelligence, machine learning, and genomics to develop cancer therapies and improve the drug development process. Its RADR platform analyzes clinical, genomic, molecular, and drug response data to identify biomarkers, predict patient responses, evaluate drug combinations, and guide clinical trial design. The company develops targeted therapies across multiple cancer indications.

Insitro

Insitro is a company that stands at the intersection of human biology and machine learning redefining drug discovery and development.

Insitro is a drug discovery and development company that combines machine learning with large-scale human and cellular data to identify disease targets and design new medicines. Its platform uses AI to study disease biology and develop small molecules, oligonucleotides, and biologics. Insitro also uses automated laboratory systems and clinical data to support drug discovery and therapeutic development.

Deep Genomics

Deep Genomics is in the field of drug discovery and development using AI to identify novel targets for therapeutic intervention.

Deep Genomics develops RNA-based therapies using artificial intelligence. Their AI platform analyzes genomic data to identify therapeutic targets and design drug candidates for genetic diseases. The company focuses on treating metabolic disorders and neurological conditions. Their proprietary technology, including the AI Workbench and BigRNA foundation model, enables efficient discovery of novel biological mechanisms and potential treatments that traditional methods might miss.

Cyclica

Cyclica is a trailblazer in the field of drug discovery, leveraging the power of artificial intelligence to develop new medicines.

Cyclica (acquired by Recursion) is a biotechnology company that uses artificial intelligence and computational biophysics to revolutionize drug discovery. Their innovative platform combines ligand design for multi-targeted drug creation and ligand express for off-target profiling. This approach allows for the efficient development of novel therapeutics while minimizing unwanted side effects. Cyclica’s technology enables faster, more cost-effective drug discovery processes, focusing on areas such as central nervous system disorders, oncology, and autoimmune diseases.

BenevolentAI

BenevolentAI is a healthcare company revolutionizing the field of drug discovery and development with its innovative use of AI.

BenevolentAI is a technology company that uses artificial intelligence to accelerate drug discovery and development. They combine machine learning with scientific expertise to analyze vast amounts of biomedical data, identify potential drug targets, and predict drug candidates.